Cipla CEO Umang Vohra Reportedly Steps Down – What It Means for India’s Pharma Industry In a surprising turn of events, Umang Vohra, the long-serving CEO and Managing Director of Cipla Ltd , is reportedly stepping down. Cipla, one of India’s leading pharmaceutical giants, has been a household name for decades—synonymous with affordable medicines and global healthcare innovation. TOI Vohra’s leadership has been instrumental in shaping Cipla’s vision and expanding its international presence. His reported exit has raised many questions about the future direction of the company and its role in India’s booming pharmaceutical sector. Umang Vohra’s Journey Umang Vohra joined Cipla in 2015 as the Global Chief Financial and Strategy Officer before becoming CEO in 2016. Under his leadership, Cipla focused on: Expanding its generic drug portfolio globally. Strengthening its presence in respiratory care and oncology . Driving digital transformation and operational efficiency...